Skip to Main Content

Paper Details

A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence.
Clin Transl Sci
1
2022
Author NameAffiliation
Nihal El RoubyDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida
Nihal El RoubyDepartment of Pharmacy Practice and Administrative Sciences, University of Cincinnati
Taimour Y LangaeeDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida
Julie A JohnsonDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida
Larisa H CavallariDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida
  • 1 - 5

Datasets